Johnson & Johnson

NYSE: JNJ
$160.88
-$2.79 (-1.7%)
Closing Price on October 25, 2024

JNJ Articles

Of the 30 Dow Jones Industrial Average stocks, only five of them have outperformed analyst expectations this year, though some have outperformed analyst expectations handily.
Johnson & Johnson released a better-than-expected third-quarter report before the markets opened on Tuesday.
Johnson & Johnson is expected to release its most recent earnings report before the markets open on Tuesday.
A third of the Dow Jones Industrial Average is reporting quarterly results this week, which has the potential to push the Dow back up to its highs.
Here are four Dow stocks that have raised their dividends for 50 years or more, and that also appear to be able to keep raising their dividends in the years ahead.
These corporate giants have stated or admitted on their own that they are in the 25-year dividend hike game.
A unit of Johnson & Johnson has announced that the FDA has approved its Stelara for the treatment of moderately to severely active Crohn's disease.
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.
August 22, 2016: Markets opened lower again Monday as investors remain cautious ahead of the Fed’s Jackson Hole conference beginning Thursday. Fed Chairwoman Janet Yellen is scheduled to speak on...
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Johnson & Johnson, Lockheed Martin, MGIC Investment, TransCanada and Verizon Communications.
July 19, 2016: Markets opened mixed on Tuesday with the blue chips opening lower before bouncing higher. Unlike the S&P 500 Index and the Nasdaq Composite, which never traded higher at any moment...
As one of the largest health care companies on the market, Johnson & Johnson helps set a direction for the industry. Strength within its pharmaceutical segment helped push this company to new...
Johnson & Johnson is set to release its second-quarter earnings report before the markets open on Tuesday, a period in which it agreed to acquire a privately held company focused on hair care and...
One-third of the 30 Dow stocks are reporting quarterly results between July 18 and 22. The main question is whether these earnings can push the Dow to new highs.